Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 12;8(1):645.
doi: 10.1038/s41598-017-17683-6.

Detection of Apparent Cell-free M. tuberculosis DNA from Plasma

E S Click  1 , W Murithi  2 , G S Ouma  2 , K McCarthy  3 , M Willby  3 , S Musau  2 , H Alexander  3 , E Pevzner  3 , J Posey  3 , K P Cain  4
Affiliations

Detection of Apparent Cell-free M. tuberculosis DNA from Plasma

E S Click et al. Sci Rep. .

Abstract

New diagnostics are needed to improve clinicians' ability to detect tuberculosis (TB) disease in key populations such as children and persons living with HIV and to rapidly detect drug resistance. Circulating cell-free DNA (ccfDNA) in plasma is a diagnostic target in new obstetric and oncologic applications, but its utility for diagnosing TB is not known. Here we show that Mycobacterium tuberculosis complex DNA can be detected in plasma of persons with sputum smear-positive TB, even in the absence of mycobacteremia. Among 40 participants with bacteriologically-confirmed smear-positive TB disease who had plasma tested by quantitative PCR (qPCR), 18/40 (45%) had a positive result on at least one triplicate reaction. Our results suggest that plasma DNA may be a useful target for improving clinicians' ability to diagnose TB. We anticipate these findings to be the starting point for optimized methods of TB ccfDNA testing and sequence-based diagnostic applications such as molecular detection of drug resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. WHO, Global Tuberculosis Report.: Geneva (2016).
    1. Boehme CC, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2011;363(11):1005–15. doi: 10.1056/NEJMoa0907847. - DOI - PMC - PubMed
    1. Boehme, C. C. et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 377(9776), 1495–505 (2011). - PMC - PubMed
    1. Dartois V, et al. New Evidence for the Complexity of the Population Structure of Mycobacterium tuberculosis Increases the Diagnostic and Biologic Challenges. Am J Respir Crit Care Med. 2016;194(12):1448–1451. doi: 10.1164/rccm.201607-1431ED. - DOI - PMC - PubMed
    1. Gregg AR, et al. Noninvasive prenatal screening by next-generation sequencing. Annu Rev Genomics Hum Genet. 2014;15:327–47. doi: 10.1146/annurev-genom-090413-025341. - DOI - PubMed

Publication types